In addition, in response to the immune evasion characteristics of lung cancer cells during immunotherapy, the immunogenicity of lung cancer cells can be altered through cellular senescence induction, for example, lung cancer cells undergoing cellular senescence express high levels of the lung‐specific antigen LUNX.197. Here, BPIFA1 is linked to lung carcinoma.